10-K: Aeluma Inc. Reports FY26 Results, Focuses on Commercialization

Aeluma, Inc. filed its annual report for the fiscal year ended June 30, 2026, detailing progress in technology development and customer engagement, while acknowledging ongoing operational and financial challenges.

Summary

• Aeluma, Inc. reported its annual results for the fiscal year ended June 30, 2026.
• The company is transitioning from an R&D stage to commercialization, focusing on high-performance photonic and electronic technologies for various applications.
• Revenue for FY2026 was $4.5 million, a slight decrease from $4.7 million in FY2025, primarily from government contracts.
• Operating expenses increased significantly by 115% to $14.6 million in FY2026, driven by increased material purchases and compensation costs.
• The company reported a net loss of $9.2 million for FY2026, an increase from $3.0 million in FY2025.
• Aeluma raised approximately $60 million through public offerings and has an active at-the-market program with $29.3 million remaining capacity.
• The company has a strong cash position of $56.0 million as of June 30, 2026, with net working capital of $55.4 million.
• A material weakness in internal control over financial reporting was identified due to insufficient personnel with technical accounting expertise, though remediation efforts are underway.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a cautiously optimistic outlook, with significant potential but also substantial risks and a long path to profitability.

Positives

• Significant increase in cash and cash equivalents to $56.0 million as of June 30, 2026, providing substantial runway.
• Active at-the-market (ATM) offering program with $29.3 million in remaining capacity for future capital needs.
• Secured new government contracts with NASA, SUNY, and the Office of the Secretary of Defense.
• Letter of intent for up to $30 million in proposed funding under the CHIPS Act, supporting R&D of its manufacturing platform.
• Expansion of R&D and prototyping capabilities with new equipment and extended facility lease through March 2031.
• Increased customer and partner engagement across key markets like AI datacom, defense, and quantum.
• Transitioning towards commercialization with initial commercial sales orders received.

Negatives

• Net loss increased by 203% to $9.2 million for FY2026.
• Operating expenses surged by 115% to $14.6 million in FY2026.
• Revenue decreased by 4% to $4.5 million in FY2026.
• Identified a material weakness in internal control over financial reporting.
• Significant dependence on government contracts and a limited number of customers.
• The company is still in the early development stages and not in volume production for any product.
• Potential for significant dilution to existing stockholders due to ongoing financing needs.

Risks

• Limited operating history and early development stage with no assurance of achieving profitability or sustaining it.
• Dependence on government contracts, which are subject to budgetary cycles, funding authorizations, and termination for convenience.
• Reliance on a limited number of customers, with the loss of any one customer potentially having a material adverse effect.
• Susceptibility to manufacturing delays and pricing fluctuations due to dependence on third-party manufacturers.
• Intense competition in the semiconductor and photonics markets from established players with greater resources.
• Potential for significant dilution of stockholders' ownership interests if additional capital is raised through equity financing.
• The company has identified material weaknesses in its internal control over financial reporting.
• Uncertainty regarding the timing and scale of commercialization, dependent on technical performance, customer qualification, and market demand.

Future Outlook

The company expects to continue investing in engineering, materials growth, wafer fabrication, packaging, testing, quality systems, sales, and business development. Commercialization timing and scale depend on technical performance, customer qualification, supply chain readiness, and market demand. Aeluma anticipates needing additional financing to support long-term growth initiatives.

Management Comments

• Management continues to monitor capital market conditions and may consider other future financing if needed.
• The proceeds from completed offerings have provided near-term capital to support operations and ongoing development efforts.
• Management believes that its current cash and cash equivalents, cash flow from operations, and ATM program capacity will be sufficient to fund business operations and capital expenditures for the next twelve months and beyond.

Industry Context

StockSavvy.ai notes that Aeluma operates in the highly competitive and rapidly evolving semiconductor, sensor, and photonics markets. The company's strategy to leverage large-diameter substrates and external fabrication aligns with industry trends towards capital efficiency, but also introduces dependencies on third-party partners.

Comparison to Industry Standards

• Silicon CMOS image sensors are widely used in high-volume consumer and automotive applications due to low cost and integration, a benchmark Aeluma aims to surpass with compound semiconductor performance.
• Traditional InGaAs sensor suppliers like Hamamatsu, Sumitomo, and Teledyne FLIR typically use smaller InP substrates, whereas Aeluma targets large-diameter substrates for potential cost advantages and higher volume production.
• In laser and optical communications, Aeluma competes with established InP, GaAs suppliers, silicon photonics companies, and integrated light source providers.
• The company's quantum photonics technology may compete with solutions based on lithium niobate, aluminum nitride, barium titanate, silicon, and silicon nitride.

Legal Proceedings

• Not currently involved in any material legal proceedings.
• Anticipates involvement in legal proceedings, claims, and litigation arising in the ordinary course of business.

Stakeholder Impact

• Shareholders may experience significant dilution if additional equity financing is pursued.
• Investors should note the identified material weakness in internal controls, which could impact financial reporting reliability.
• Customers in regulated industries may be affected by changes in laws and regulations impacting their costs or operations.
• Suppliers and manufacturing partners are critical to the supply chain, and disruptions could impact Aeluma's ability to deliver products.

Next Steps

• Advance product development.
• Complete customer and manufacturing qualifications.
• Deliver on existing commercial and government contracts.
• Increase manufacturing readiness.
• Convert qualified customer engagements into recurring product revenue.
• Continue investing in engineering, materials growth, wafer fabrication, packaging, testing, quality systems, sales, and business development.
• Work with prospective customers, system integrators, module manufacturers, and other partners.
• Establish repeatable, qualified production flows with external foundries and partners.

Key Dates

Recommendation

Aeluma shows promising technological advancements and a strong cash position, but the increased net loss, rising operating expenses, and identified material weakness in internal controls warrant a cautious approach. The company is still in a pre-revenue growth phase with significant execution risk, making a 'hold' recommendation appropriate until clearer signs of commercial traction and improved financial performance emerge.

Keywords

photonic technologies, electronic technologies, AI datacom, semiconductor, compound semiconductor, heterogeneous integration, quantum dot lasers, SWIR photodetectors